IQVIA

IQVIA, headquartered in Durham, North Carolina, is unequivocally the world’s leading and largest provider of advanced analytics, cutting-edge technology solutions, and global clinical research services strictly dedicated to the life sciences industry. Formed through the historic, massive mega-merger of IMS Health and Quintiles, IQVIA possesses an unprecedented, globally unparalleled capability: perfectly combining the world’s absolute largest healthcare data repository with world-class, massive-scale global clinical trial execution.

The organization operates robustly in over 100 countries, employing an astounding workforce of approximately 88,000 highly trained professionals. As a Clinical Research Organization (CRO), IQVIA actively utilizes its vast, proprietary data—securely covering hundreds of millions of anonymized patient records globally—to fundamentally optimize and accurately predict clinical trial design, precise site selection, and rapid patient recruitment. This highly data-driven approach, officially coined by the company as “Human Data Science,” drastically and consistently reduces trial timelines and costly failure rates.

Beyond massive clinical operations, IQVIA provides absolutely critical commercial outsourcing, vast real-world evidence (RWE) generation, and highly complex global regulatory consulting. Their advanced technology platforms seamlessly integrate decentralized trial functionalities, Electronic Data Capture (EDC), and rigorous safety reporting.

Functioning as an undisputed industry titan, IQVIA partners closely with essentially every major pharmaceutical, biotechnology, and medical device company globally to navigate the complex pathways of bringing innovative therapies to market.